🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🗽Join me in NYC this summer to explore the most controversial clinical issues in the field of hematologic malignancies! Network with local experts and bring best practices back to your clinic. Register for free using my last name as a discount code: shorturl.at/Cdsdf

Hear Courtney DiNardo, MD, MSCE, of MD Anderson Cancer Center Rami komrokji, of Moffitt Cancer Center and Amer Zeidan MBBS,MHS ‏عامر زيدان of Yale School of Medicine discuss primary therapeutic goals for patients with intermediate- to high-risk myelodysplastic syndromes. Watch the full video here: hubs.li/Q03lp2fy0

Beautiful day in #Rotterdam Visit Netherlands for the MDS Foundation Meeting #2025 — honored to be here in this stunning city. Great opening by G Garcia-Manero on #HR-MDS and an exciting agenda ahead. Looking forward to an inspiring few days! #MDS25 MDS Foundation UTSW Simmons Cancer Center

Beautiful talk by Oni deciphering #TP53 in #MDSsm at the single cell level. Kristian Gurashi #MDS25 MDS Foundation International Consortium for MDS (icMDS) MDS Hub AA&MDSIF

Honoring two giants in #MDSsm at the #MDSF25 MDS Foundation biennial meeting in Rotterdam with life achievement awards to Dr John Bennett (who just turned 91) & Dr Peter Greenberg for their life long immense contributions to the field. We truly stand on the shoulders of giants!

#LifetimeAchievementAward — Humbled to witness two legends, Drs. John Bennett and Peter Greenberg, accept this well-deserved honor. #Remarkable moment led by Stephen D. Nimer, MD — celebrating their lasting impact on MDS. What a way to close the morning session #MDS25 MDS Foundation

BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia | Blood | American Society of Hematology ⁦Blood Journal⁩ ⁦Mrinal Patnaik⁩ ⁦Guillermo Montalban-Bravo⁩ #CMML #hemepath ashpublications.org/blood/article/…

we need UBA1 in our myeloid panels .. pls Beautifully delivered presentation by Maria Sirenko 👏🏼#MDS25 MDS Foundation #MDSsm Elsa Bernard Elli Papaemmanuil, PhD

Great talk on #VEXAS syndrome by David Beck ⁦MDS Foundation⁩ meeting #mds2025

Fantastic talk by Amer Zeidan MBBS,MHS ‏عامر زيدان Yale Cancer Center at #MDS25 MDS Foundation, using '#BoulevardofBrokenDreams' to describe the challenges in higher-risk MDS drug development. #The18thInternationalCongress on #MDS youtu.be/Soa3gO7tL-c?si…

🎉 Congratulations to Professor James Brugarolas , founding director of the UTSW-Kidney Cancer Program, on his election to the Association of American Physicians (AAP)!

Plenary #5 at #MDS25 in #Rotterdam: Drs. Ulrich Germing, Rob Hasserjian & Amer Zeidan MBBS,MHS ‏عامر زيدان delivered a thoughtful and forward-looking update on the 2025 WHO/ICC classification. There’s a light at the end of the tunnel—and it’s molecularly informed. 💡🧬 MDS Foundation Visit Netherlands

Join us for a live webinar with Vivian Irizarry Gatell, M.D., as she discusses the unique and comprehensive treatments, multi-faceted support, and survivorship resources that younger patients need, why it’s important, and how we can help. Register here: bit.ly/4keHJeG.

New in Leukemia Journal : Outcomes in intensively treated KMT2Ar #AML have improved over time. But low-intensity therapies still show poor results — highlighting the urgent need to explore menin inhibitors nature.com/articles/s4137… #leusm

Finally out: how to deal with anemia in #VEXAS?? #MDS therapy helps us! Check the Italian 🇮🇹 experience onlinelibrary.wiley.com/doi/pdfdirect/…

Our new publication is out today in the OnlineFirst section of Blood Cancer Discovery! We explored correlations between monocytic AML, genetics, and survival by leveraging a large international clinical cohort of patients with AML treated with HMA+VEN. aacrjournals.org/bloodcancerdis…

Hot off the press! Our GEN-PHEN-VEN study led by Curtis Lachowiez showing the importance of phenotype for risk class. of AML Tx w/ Aza/Ven. Monocytic diff. associated w/ worse outcomes and should be part of our risk class. Glad to be part of this impactful analysis UNC Lineberger

#Clone size matter! Sharing our manuscript at Blood Neoplasia here ! Moffitt Cancer Center

We are honored to congratulate Wendy Stock of UChicagoCancerCenter for her 2025 Giants of Cancer Care Leukemia induction! #GiantsCC25 #leusm

Congratulations to all ASCO Conquer Cancer, the ASCO Foundation #CDA & #YIA recipients! Carlos L. Arteaga, M.D. Suzanne Conzen Dr. Andy Wang 🇺🇦 & I are super proud of Charles Jiang MD, MPH UTSW Simmons Cancer Center UTSW Hematology & Oncology — He is one to watch - doing great work with outcomes & trial access for our patients! #ASCO25